Clinical Trials Logo

Clinical Trial Summary

The study is investigating new medicines for weight control in people with high body weight. The study looks at how the study medicines work in the body. Participants will get semaglutide and either NNC0165-1562 or "dummy" medicine -which treatment participants get is decided by chance. Participants will get 2 injections per week for 5 months. A study nurse at the clinic will inject the medicine with a thin needle in a skin fold in the stomach. The study will last for about 7 months. Participants will have 27 visits to the clinic.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03574584
Study type Interventional
Source Novo Nordisk A/S
Contact Novo Nordisk
Phone (+1) 866-867-7178
Status Recruiting
Phase Phase 1
Start date June 18, 2018
Completion date August 22, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02823912 - Capsaicin Effect on Cytokines Profile in Dyslipidemia Phase 2/Phase 3
Active, not recruiting NCT03548935 - STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity Phase 3